Hints and tips:
...Shockwave has an existing partnership with J&J-owned Abiomed, after Abiomed invested $15mn in Shockwave in 2018....
...J&J’s $380 a share cash offer values Abiomed’s equity at around $17.3bn....
...Abiomed shares surged about 51 per cent shortly after Wall Street’s opening bell on Tuesday, while J&J was down 0.3 per cent....
...Johnson & Johnson announced in November it had struck a deal to acquire cardiovascular technology group Abiomed for $16.6bn, while Pfizer said in May it had agreed to buy US biotech Biohaven Pharmaceuticals...
...It has only been a part of the S&P 500 for a month, but medical-device maker Abiomed has already made a splash as the index’s top gainer during the first half of 2018....
...There are 71 companies in the tech- and biomed-heavy Nasdaq Composite, besides Netflix and Abiomed, that are up by 100 per cent or more so far this year....
International Edition